Reuss, David E.; Downing, Susanna M.; Camacho, Cristel V. et al.
Simultaneous <i>Nbs1</i> and <i>p53</i> inactivation in neural progenitors triggers high-grade gliomasNEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. Bd. 49. H. 4. 2023
Guel, Desiree; Kraemer, Oliver H.; Reinhardt, Christoph
Starving out brain tumors: a reprogrammed lysine catabolism serves as a novel target for glioblastoma treatmentSIGNAL TRANSDUCTION AND TARGETED THERAPY. Bd. 8. H. 1. 2023
Koeberle, Beate; Usanova, Svetlana; Piee-Staffa, Andrea et al.
Strong apoptotic response of testis tumor cells following cisplatin treatmentINTERNATIONAL UROLOGY AND NEPHROLOGY. 2023
Kaina, Bernd
Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic ImplicationsJOURNAL OF CLINICAL MEDICINE. Bd. 12. H. 23. 2023
Kiweler, Nicole; Helena, Schwarz; Nguyen, Alexandra et al.
The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracilCELL BIOLOGY AND TOXICOLOGY. Bd. 39. H. 5. 2023 S. 2401-2419
Schmidt, A.; Kitzinger, R.; Poeschmann, A. et al.
Threshold concentrations for BPDE-induced cell death are characterised by altered DNA damage signalling and associated with unrepaired double-strand breaksNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 396. 2023 S. S33-S34
Beltzig, Lea; Christmann, Markus; Kaina, Bernd
Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for SenolyticsCELLS. Bd. 11. H. 16. 2022
Fauss, Julian; Sprang, Bettina; Leukel, Petra et al.
ALDH1A3 Segregated Expression and Nucleus-Associated Proteasomal Degradation Are Common Traits of Glioblastoma Stem CellsBIOMEDICINES. Bd. 10. H. 1. 2022
Vilar, Juliana B.; Christmann, Markus; Tomicic, Maja T.
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?CANCERS. Bd. 14. H. 10. 2022
Hanisch, Daniela; Krumm, Andrea; Diehl, Tamara et al.
Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expressionCELL DEATH & DISEASE. Bd. 13. H. 4. 2022